Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis

Figure 1 Gene expression levels of UBE2C, UBE2T, and UBE2S in pan-cancer with normal samples and tumor samples (the Cancer Genome Atlas database). N: Normal samples; C: Cancer samples. Color-coded only based on each cancer type. Red: higher expression level; Blue: lower expression level when compared tumor samples with normal samples in a particular cancer type. The number represents the median value of expression Log2 (transcript count per million (TPM)+1). The total sample number for the corresponding cancer type was listed on the right side of the figure (N: total sample number of normal samples. C: total sample number of tumor samples) Abbreviations: BLCA: Bladder urothelial carcinoma; BRCA: Breast invasive carcinoma; CESC: Cervical squamous cell carcinoma; CHOL: Cholangiocarcinoma; COAD: Colon adenocarcinoma; ESCA: Esophageal carcinoma; GBM: Glioblastoma multiforme; HNSC: Head and Neck squamous cell carcinoma; KICH: Kidney Choromophobe; KIRC: Kidney renal clear cell carcinoma; KIRP: Kidney renal papillary cell carcinoma; LIHC (HCC): Liver hepatocellular carcinoma; LUAD: Lung adenocarcinoma; LUSC: Lung squamous cell carcinoma; PAAD: Pancreatic adenocarcinoma; PRAD: Prostate adenocarcinoma; PCPG: Pheochromocytoma and Paraganglioma; READ: Rectum adenocarcinoma; SARC: Sarcoma; SKCM: Skin Cutaneous Melanoma; THCA: Thyroid carcinoma; UCS: Uterine Carcinosarcoma; THYM: Thymoma; STAD: Somach adenocarcinoma; UCEC: Uterine Corpus Endometrial Carcinoma)